Loading
If this is the first time anyone has visited this substance, we may be fetching live data from TGA Product Information, PBS, and state framework sources — that can take up to a minute. Cached substances load in a second or two.
Chemotherapy-induced neutropenia Clinical criteria: Patient must be receiving chemotherapy with the intention of achieving a cure or a substantial remission, AND Patient must be at greater than 20% risk of developing febrile neutropenia; OR Patient must be at substantial risk (greater than 20%) of prolonged severe neutropenia for more than or equal to seven days.
“Human G-CSF is a glycoprotein which regulates the production and release of neutrophils from the bone marrow.”
“The terminal elimination half-lives of the corresponding age groups were 20.2 (± 11.3) hours, 21.2 (± 16.0) hours and 30.1 (± 38.2) hours respectively.”
Curated subset. The full adverse-effect list is in the TGA Product Information; click any citation above to open it.